Li, K. K., Shi, Z., Malta, T. M., Chan, A. K., Cheng, S., Kwan, J. S. H., . . . Ng, H. (2019). Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neurooncol Adv.
Chicago Style CitationLi, Kay Ka-Wai, et al. "Identification of Subsets of IDH-mutant Glioblastomas With Distinct Epigenetic and Copy Number Alterations and Stratified Clinical Risks." Neurooncol Adv 2019.
Cita MLALi, Kay Ka-Wai, et al. "Identification of Subsets of IDH-mutant Glioblastomas With Distinct Epigenetic and Copy Number Alterations and Stratified Clinical Risks." Neurooncol Adv 2019.
Atenció: Aquestes cites poden no estar 100% correctes.